BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Drug Discovery

Formosa Pharmaceuticals Grants Exclusive ASEAN Rights For APP13007 To Rxilient Medical

Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Rxil...

December 04, 2025 | News

Antengene Secures Expanded Approvals For Xpovio In Hong Kong Across Multiple Myeloma And DLBCL

- XPOVIO® (selinexor) has received approvals for three indications in Hong Kong. These include its previous approval as the treatment for mul...

December 04, 2025 | News

AGC Biologics Strengthens Global Cell Line Capabilities With ATUM Partnership and Leap In Technology

New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex mole...

December 04, 2025 | News

Samsung Bioepis Gains CHMP Backing for BYOOVIZ Pre Filled Syringe

European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopts positive opinion for BYOOVIZ® (ranibizuma...

December 03, 2025 | News

Fujitsu Develops Multi AI Agent Collaboration Technology for Secure and Resilient Supply Chains

Fujitsu Limited announced the development of a multi-AI agent collaboration technology that enables secure collaboration and swift response to changin...

December 02, 2025 | News

Asia PGI Unveils PathGen as a Federated AI Platform for Early Outbreak Intelligence

Asia-led, "sovereign-by-design" platform built for secure, decentralised pathogen intelligence-sharing across borders aims to break data silos and provide ...

December 02, 2025 | News

Generate Plans Global Phase 3 Trials for AI Engineered GB 0895 in Severe Asthma

Generate:Biomedicines ("Generate") announced it plans to initiate two global Phase 3 clinical trials, SOLAIRIA-1 and SOLAIRIA-2, evaluating GB-0895 in appr...

December 02, 2025 | News

Ascletis Advances First Oral Triple Agonist for Obesity, ASC37, into Clinical Development

- Utilizing Ascletis' Peptide Oral Transport ENhancement Technology (POTENT), ASC37 oral tablets achieved average absolute oral bioavailability ...

December 01, 2025 | News

IASO Bio Achieves Landmark Hong Kong Approval for Fucaso CAR-T Therapy

IASO Biotechnology ("IASO Bio"), a commercial-stage biopharmaceutical company dedicated to the discovery, development, manufacturing, and commerciali...

November 28, 2025 | Regulatory

Zydus and RK Pharma Partner on Innovative Sterile Injectable for Oncology Supportive Care

Zydus Lifesciences Ltd. (including its subsidiaries and affiliates), a global innovation-driven healthcare company, announced that it has entered into an e...

November 27, 2025 | News

mAIbe and LenioBio Form Strategic Partnership to Accelerate Next-Gen Antibody Discovery

mAIbe and LenioBio are pleased to announce a new strategic collaboration aimed at accelerating the discovery and experimental validation of next-generation...

November 27, 2025 | News

The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech

Global pharmaceutical companies are racing to tap China’s new AI-powered biotech platforms to discover drugs faster and cheaper. In 2025, major Weste...

November 27, 2025 | Analysis

Accord BioPharma Gains FDA Approval for Two Denosumab Biosimilars to Expand Access to Osteoporosis and Cancer Related Bone Care

Products will treat osteoporosis and skeletal-related events from certain types of bone cancer, expanding the company's biosimilar portfolio Accord BioPha...

November 21, 2025 | News

Hoth Therapeutics Joins NVIDIA Connect Program to Advance AI Driven Drug Discovery

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company focused on developing breakthrough therapeutics announced that it h...

November 21, 2025 | News

Stay Connected